TBI-166
TBI-166 is an orally bioavailable riminophenazine compound developed as a next-generation anti-tuberculosis agent. It demonstrates potent activity against Mycobacterium tuberculosis in both in vitro and in vivo models while exhibiting an improved safety profile compared to Clofazimine.
Product Specifications
CAS Number
1353734-12-9
Field of Research
Infectious Disease & Virology
Smiles
N (=C1C=C2N (C=3C (N=C2C=C1NC4=C (OC) N=CC=C4) =CC=CC3) C5=CC=C (OC (F) (F) F) C=C5) C6CCC (OC) CC6
Molecular Formula
C32H30F3N5O3
Molecular Weight
589.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog